Elevance Health, Inc.
As of Oct 22, 2026, Elevance Health is in Stage 2, the uptrend phase, now in week 6 (since Sep 17, 2026). It closed at $445.28, at its 52-week high and above its 200-day average, which is rising.
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. More about the company
Pro read
ProOur read
Setup score
Momentum
Edge
Setup-score rank among Stage 2 peers: #1 of 5 in Healthcare Plans · #1 of 272 in Health Care
Is ELV early, or has it already run? Pro answers that for every US stock we cover, after every close.
Renews monthly until you cancel. Cancel any time in Plan & billing.
ELV among Healthcare Plans6th of 11 by relative strength
All 11 →| # | Stock | Stage | RS | 1M |
|---|---|---|---|---|
| 1 | CNC | Stage 2 · wk 1 | 94 | +14.8% |
| 2 | OSCR | Stage 2 · wk 22 | 87 | +9.1% |
| 3 | PGNY | Stage 3 · wk 7 | 86 | +12.7% |
| 4 | CLOV | Stage 2 · wk 2 | 85 | +3.5% |
| 5 | HUM | Stage 2 · wk 2 | 84 | +12.3% |
| 6 | ELV | Stage 2 · wk 6 | 76 | +11.7% |
| 7 | UNH | Stage 3 · wk 7 | 69 | +14.5% |
| 8 | CVS | Stage 3 · wk 7 | 68 | +10.8% |
Elevance Health: quick answers
What stage is Elevance Health in?
As of Oct 22, 2026, Elevance Health (ELV) is in Stage 2, the uptrend phase. It entered Stage 2 on Sep 17, 2026 and is in week 6. What the four stages mean
Is Elevance Health in an uptrend?
Yes. Elevance Health is in a Stage 2 uptrend. It trades 20.9% above its 200-day average, which is rising.
How far is Elevance Health from its 52-week high?
Elevance Health closed at $445.28 on Oct 22, 2026, at its 52-week high. Its 52-week low is $276.69.
How has Elevance Health performed over the past year?
As of Oct 22, 2026, Elevance Health is up 29.8% over the past year and up 27.5% so far in 2026.
Which sector and industry is Elevance Health in?
Elevance Health is in the Healthcare Plans industry, part of the Health Care sector.
About this companyHealth Care· Healthcare Plans
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits. The company also operates in the pharmacy services business; and markets and offers pharmacy services, including home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services, as well as infusion services and injectable therapies through ambulatory infusion centers. In addition, it provides healthcare related services and capabilities, including specialty care enablement and utilization management support for specialized clinical domains; behavioral health and comprehensive care management services; palliative care services and management; virtual care; and payment integrity, subrogation, clinical data exchange through its HealthOS platform, research and data, reporting and clinical analytics, information technology, and business process support services, as well as manages home health, post-acute institutional management, and durable medical equipment costs; and supports plans in managing home and community-based services. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brands. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is based in Indianapolis, Indiana.
Visit company website →All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.